Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 20 images provide visual information about the product associated with Pregabalin NDC 80425-0397 by Advanced Rx Of Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Pregabalin 150mg #30 - Pregabalin 150mg 80425 0397 01
Pregabalin 150mg #60 - Pregabalin 150mg 80425 0397 02
Packed by Slore at 288 degrees Celsius, this is a Pregabalin 150mg capsule with Lot number 0000 and expiry date 1/31/3027. It is supplied by PHARNAC.*
Pregabalin 150mg #90 - Pregabalin 150mg 80425 0397 03
Pregabalin 225mg #30 - Pregabalin 225mg 80425 0399 01
Pregabalin 225mg #60 - Pregabalin 225mg 80425 0399 02
This text contains information about pharmaceutical products. It mentions PREGABALIN 225MG CAPSULES and LASCAMNBSNG CAPSULES. The indicated quantities are 60 and 90 capsules respectively with Lot XOO0000K with an expiration date of 1/31/2027. The manufacturer is SCIEGEN PHARMACEUTICALS.*
Pregabalin 225mg #90 - Pregabalin 225mg 80425 0399 03
This is a pack of 90 capsules of Pregabalin 225mg each. It is packed by Shore Street at 26°C (80°F) and has an expiration date of 1/31/2027. The lot number is 00000. Manufactured by Sciegen Pharmaceuticals.*
Figure 1 - pregabalin fig01
Figure 2 - pregabalin fig02
Figure 3 - pregabalin fig03
Percent of Patients Improved by using Pregabalin and Pregabain for pain treatment: Pregatalin 300 mg two times a day, Pregabain 160 mg two times a day, Pregabalin 75 mg two times a day. The study indicates a percentage of improvement in pain for the patients.*
Figure 4 - pregabalin fig04
This text seems to provide information about the improvement in pain of patients who are parents. The text mentions the medication pregabalin with different dosages and a placebo. The pain improvement is measured from a baseline and appears to be significant.*
Figure 5 - pregabalin fig05
Figure 6 - pregabalin fig06
This text provides information on a study comparing different dosages of a medication with a placebo. The dosages evaluated are 50mg/day, 150mg/day, 300mg/day, and 600mg/day. The results indicate that there is statistical significance observed between the medication dosages and the placebo group.*
Figure 7 - pregabalin fig07
Figure 9 - pregabalin fig08
This is a chart showing the percent improvement in pain from baseline for different doses of pregabalin (300mg and 450mg daily) compared to a placebo. The chart indicates that the 450mg daily dose of pregabalin resulted in a higher percentage of patients showing improvement compared to the 300mg dose and the placebo.*
Figure 10 - pregabalin fig09
Figure 11 - pregabalin fig10
Figure 12 - pregabalin fig11
This is a table showing the percentage of subjects improved with Pregabalin and Placebo from baseline to week 16 in a study. It indicates that 100% of subjects improved with Pregabalin, while Placebo had 280 to 200 percent improvement.*
Figure 13 - pregabalin fig13
Cockcroft and Gault equation - pregabalin formula
This is a formula for calculating creatinine clearance (CLCT) in a patient, which is a measure of kidney function. The formula takes into account the patient's age, weight, and serum creatinine levels. It also specifies an adjustment for female patients by multiplying the result by 0.85.*
Chemical Structure - pregabalin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.